US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Ongoing

Enalapril Maleate Tablets

Reason CGMP Deviations

Golden State Medical Supply Inc. NDC 60429-183-90 D-1177-2022
Class III · Low risk Terminated

Atorvstatin Calcium Tablets

Reason Failed Impurities/Degradation Specifications: Out of Specification results for related substance.

Dr. Reddy's Laboratories, Inc. NDC 55111-124-90 D-0726-2022
Class II · Moderate risk Terminated

Lidocaine Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 50383-341-35 D-0705-2022
Class II · Moderate risk Terminated

Lidocaine Cream 4%

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 0536-1281-28 D-0704-2022
Class II · Moderate risk Terminated

Hydrocortisone Butyrate Lotion

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-032-04 D-0703-2022
Class II · Moderate risk Terminated

Gentamicin Sulfate Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-036-30 D-0702-2022
Class II · Moderate risk Terminated

Diflorasone Diacetate Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-063-60 D-0701-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-028-60 D-0700-2022
Class II · Moderate risk Terminated

Triamcinolone Acetonide Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-014-15 D-0699-2022
Class II · Moderate risk Terminated

Triamcinolone Acetonide Lotion USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-010-59 D-0698-2022
Class II · Moderate risk Terminated

Triamcinolone Acetonide Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-056-15 D-0697-2022
Class II · Moderate risk Terminated

Triamcinolone Acetonide Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-048-15 D-0696-2022
Class II · Moderate risk Terminated

Nystatin and Triamcinolone Acetonide Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-042-15 D-0695-2022
Class II · Moderate risk Terminated

Lidocaine Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-008-14 D-0694-2022
Class II · Moderate risk Terminated

Lidocaine Cream

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-122-15 D-0693-2022
Class II · Moderate risk Terminated

Hydrocortisone Butyrate Lotion

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-087-02 D-0692-2022
Class II · Moderate risk Terminated

Halobetasol Propionate Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 63739-998-67 D-0691-2022
Class II · Moderate risk Terminated

Hydrocortisone Butyrate Lotion 0.1%

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 51862-159-04 D-0690-2022
Class II · Moderate risk Terminated

Halobetasol Propionate Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-073-15 D-0689-2022
Class II · Moderate risk Terminated

Halobetasol Propionate Ointment

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-033-50 D-0688-2022
Class II · Moderate risk Terminated

Gentamicin Sulfate Ointment USP 0.1%

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-090-15 D-0687-2022
Class II · Moderate risk Terminated

Gentamicin Sulfate Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-085-15 D-0686-2022
Class II · Moderate risk Terminated

Fluocinonide Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk Terminated

Fluocinonide Gel USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022
Class II · Moderate risk Terminated

Fluocinonide Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-079-11 D-0683-2022